Skip to content

effect of clomiphen &gonadotrophine at ovarian stimulation in poor responders .

clinical outcome following stimulation with standard antagonist &minimal stimulation in poor responders .

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015011920351N2
Enrollment
98
Registered
2015-02-05
Start date
2014-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

poor responders in IVF. Female infertility associated with anovulation

Interventions

Intervention 1: in GnRH antagonist /clomiphen group(study) , clomiphen 100 mg oral is started from day 2 until 6 day of cycle & gonadotropin with 150 IU daily SC is started from day 5 & when
Treatment - Drugs
n control group ,gonadotrophin is started from day 2 cycle at least 300 IU SC , when at least one follicle >14 is observed , 0.25 mg cetrotide SC daily is started & countiniued until follicle 18 m
in GnRH antagonist /clomiphen group(study) , clomiphen 100 mg oral is started from day 2 until 6 day of cycle & gonadotropin with 150 IU daily SC is started from day 5 & when at least one fo

Sponsors

Vice Chancellor For Research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
14 Years to 15 Years

Inclusion criteria

Inclusion criteria: Inclusion critria : IVF candidates; who are considered according to Blogna . exclusion criteria : contraindication of drug usage.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Oocyte count . Timepoint: before stimulation & 4 days & according to tvs . Method of measurement: tvs & oocyte count.

Secondary

MeasureTime frame
Pregnancy Rate. Timepoint: 14 days After E mbrio Transfer. Method of measurement: Serum B-hCG.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShamim Pilehvari

Tehran University Of Medical Sciences

sh.pilehvari@yahoo.com+98 21 6658 1616

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026